Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Net Income (Quarterly): 30.75M for Sept. 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 30.75M |
| June 30, 2023 | -4.248M |
| March 31, 2023 | -41.01M |
| December 31, 2022 | -59.01M |
| September 30, 2022 | -77.76M |
| June 30, 2022 | -62.02M |
| March 31, 2022 | -24.14M |
| December 31, 2021 | -37.17M |
| September 30, 2021 | -37.34M |
| June 30, 2021 | -30.74M |
| March 31, 2021 | -34.05M |
| December 31, 2020 | 31.39M |
| September 30, 2020 | -22.37M |
| June 30, 2020 | -24.30M |
| March 31, 2020 | -29.09M |
| December 31, 2019 | 4.814M |
| September 30, 2019 | -21.75M |
| June 30, 2019 | -43.45M |
| March 31, 2019 | -43.75M |
| December 31, 2018 | -41.80M |
| September 30, 2018 | -46.81M |
| June 30, 2018 | -41.62M |
| March 31, 2018 | -38.61M |
| December 31, 2017 | -13.12M |
| September 30, 2017 | -56.68M |
| Date | Value |
|---|---|
| June 30, 2017 | -8.867M |
| March 31, 2017 | -17.34M |
| September 30, 2016 | -44.73M |
| June 30, 2016 | -45.92M |
| March 31, 2016 | -31.93M |
| December 31, 2015 | -33.23M |
| September 30, 2015 | -33.74M |
| June 30, 2015 | -30.47M |
| March 31, 2015 | -21.62M |
| December 31, 2014 | 13.64M |
| September 30, 2014 | -22.28M |
| June 30, 2014 | -26.50M |
| March 31, 2014 | -37.45M |
| December 31, 2013 | 3.813M |
| September 30, 2013 | -11.23M |
| June 30, 2013 | -21.88M |
| March 31, 2013 | -1.351M |
| December 31, 2012 | -24.39M |
| September 30, 2012 | -25.19M |
| June 30, 2012 | -22.41M |
| March 31, 2012 | -18.67M |
| December 31, 2011 | -12.75M |
| September 30, 2011 | -19.48M |
| June 30, 2011 | -16.15M |
| March 31, 2011 | -15.00M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-77.76M
Minimum
Sep 2022
31.39M
Maximum
Dec 2020
-26.02M
Average
-29.91M
Median
Net Income (Quarterly) Benchmarks
| AbbVie Inc | 1.561B |
| Pfizer Inc | 4.465B |
| Johnson & Johnson | 2.694B |
| Merck & Co Inc | 3.157B |
| Cerevel Therapeutics Holdings Inc (DELISTED) | -131.91M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 113.42M |
| Total Expenses (Quarterly) | 87.47M |
| EPS Diluted (Quarterly) | 0.10 |
| Gross Profit Margin (Quarterly) | 98.10% |
| Profit Margin (Quarterly) | 27.11% |